Poxel Announces Detailed Imeglimin Phase 3 TIMES 1 Results Presented at 55th Annual Meeting of the European Association for the Study of Diabetes

Media coverage

• Title	Poxel Announces Detailed Imeglimin Phase 3 TIMES 1 Results Presented at 55th Annual Meeting of the European Association for the Study of Diabetes
  Media name/outlet	Morningstar.com
  Country	United States
  Date	9/18/19
  Persons	Ralph A Defronzo

• Title	Poxel Announces Detailed Imeglimin Phase 3 TIMES 1 Results Presented at 55th Annual Meeting of the European Association for the Study of Diabetes
  Media name/outlet	Finanzen.net
  Country	Germany
  Date	9/18/19
  Persons	Ralph A Defronzo

• Title	Poxel Announces Detailed Imeglimin Phase 3 TIMES 1 Results Presented at 55th Annual Meeting of the European Association for the Study of Diabetes
  Media name/outlet	Finanzen.ch
  Country	Switzerland
  Date	9/18/19
  Persons	Ralph A Defronzo

• Title	Poxel Announces Detailed Imeglimin Phase 3 TIMES 1 Results Presented at 55th Annual Meeting of the European Association for the Study of Diabetes
  Media name/outlet	MarketScreener.com
  Country	United States
  Date	9/18/19
  Persons	Ralph A Defronzo

• Title	Poxel Announces Detailed Imeglimin Phase 3 TIMES 1 Results Presented at 55th Annual Meeting of the European Association for the Study of Diabetes
  Media name/outlet	Boerse.de
  Country	Germany
  Date	9/18/19
  Persons	Ralph A Defronzo

• Title	Poxel Announces Detailed Imeglimin Phase 3 TIMES 1 Results Presented at 55th Annual Meeting of the European Association for the Study of Diabetes
  Media name/outlet	India Pharma News
  Country	India
  Date	9/18/19
  Persons	Ralph A Defronzo

• Title	Poxel Announces Detailed Imeglimin Phase 3 TIMES 1 Results Presented at 55th Annual Meeting of the European Association for the Study of Diabetes
  Media name/outlet	BioSpace
  Country	United States
  Date	9/18/19
  Persons	Ralph A Defronzo

• Title	Poxel Announces Detailed Imeglimin Phase 3 TIMES 1 Results Presented at 55th Annual Meeting of the European Association for the Study of Diabetes
  Media name/outlet	Jotup
  Country	United States
  Date	9/18/19
  Persons	Ralph A Defronzo

• Title	Poxel Announces Detailed Imeglimin Phase 3 TIMES 1 Results Presented at 55th Annual Meeting of the European Association for the Study of Diabetes
  Media name/outlet	FinanzNachrichten.de
  Country	Germany
  Date	9/18/19
  Persons	Ralph A Defronzo

• Title	Poxel Announces Detailed Imeglimin Phase 3 TIMES 1 Results Presented at 55th Annual Meeting of the European Association for the Study of Diabetes
  Media name/outlet	Erie News Now
  Country	United States
  Date	9/18/19
  Persons	Ralph A Defronzo

• Title	Poxel Announces Detailed Imeglimin Phase 3 TIMES 1 Results Presented at 55th Annual Meeting of the European Association for the Study of Diabetes
  Media name/outlet	CW WBCB
  Country	United States
  Date	9/18/19
  Persons	Ralph A Defronzo

• Title	Poxel Announces Detailed Imeglimin Phase 3 TIMES 1 Results Presented at 55th Annual Meeting of the European Association for the Study of Diabetes
  Media name/outlet	Business Wire
  Country	United States
  Date	9/18/19
  Persons	Ralph A Defronzo

• Title	Poxel Announces Detailed Imeglimin Phase 3 TIMES 1 Results Presented at 55th Annual Meeting of the European Association for the Study of Diabetes
  Media name/outlet	Business Wire
  Country	United States
  Date	9/18/19
  Persons	Ralph A Defronzo

• Title	Poxel Announces Detailed Imeglimin Phase 3 TIMES 1 Results Presented at 55th Annual Meeting of the European Association for the Study of Diabetes
  Media name/outlet	Acrofan
  Date	9/17/19
  Persons	Ralph A Defronzo